
Quotient Limited QTNT
Quartalsbericht 2022-Q4
hinzugefügt 09.02.2023
Quotient Limited Zahlungsmittel 2011-2026 | QTNT
Zahlungsmittel Jährlich Quotient Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 45.7 M | 3.4 M | 4.1 M | 20.2 M | 4.75 M | 44.1 M | 37.5 M | 7.19 M | 4.22 M | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 45.7 M | 3.4 M | 19 M |
Zahlungsmittel Vierteljährlich Quotient Limited
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11.9 M | 24.5 M | 46.2 M | 65.1 M | 85.1 M | 121 M | 115 M | 115 M | 3.4 M | 3.4 M | 18.1 M | 7.32 M | 4.66 M | 4.66 M | 5.82 M | 6.53 M | 4.47 M | 4.47 M | 3.56 M | 20.2 M | 6.15 M | 9.13 M | 13 M | 4.75 M | 14.3 M | 19 M | 22.4 M | 44.1 M | 24.1 M | 25.7 M | 21.3 M | 37.5 M | 33 M | 17.1 M | 32 M | 7.19 M | 13.8 M | 1.54 M | 1.74 M | 4.22 M | - | - | - | 4.35 M | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 121 M | 1.54 M | 25 M |
Zahlungsmittel anderer Aktien in der Diagnostik & Forschung
| Name | Zahlungsmittel | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Agilent Technologies
A
|
1.48 B | $ 110.28 | -2.82 % | $ 33.5 B | ||
|
Centogene N.V.
CNTG
|
19.1 M | - | -6.23 % | $ 30.6 M | ||
|
Enzo Biochem
ENZ
|
52.4 M | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
956 M | - | - | $ 19.8 B | ||
|
Akumin
AKU
|
59.4 M | - | -17.87 % | $ 25.9 M | ||
|
Sotera Health Company
SHC
|
345 M | $ 13.21 | -2.44 % | $ 3.75 B | ||
|
Check-Cap Ltd.
CHEK
|
7.7 M | - | - | $ 9.42 M | ||
|
Heska Corporation
HSKA
|
157 M | - | - | $ 1.31 B | ||
|
Biodesix
BDSX
|
26.2 M | $ 14.31 | -2.02 % | $ 1.86 B | ||
|
Burning Rock Biotech Limited
BNR
|
1.9 B | $ 16.41 | -11.3 % | $ 177 M | ||
|
BioNano Genomics
BNGO
|
2.99 M | $ 1.15 | -0.43 % | $ 6.26 M | ||
|
Bioventus
BVS
|
51.2 M | $ 9.03 | -2.48 % | $ 602 M | ||
|
Co-Diagnostics
CODX
|
14.9 M | $ 4.4 | 101.83 % | $ 129 M | ||
|
DermTech
DMTK
|
36.7 M | - | -11.32 % | $ 2.94 M | ||
|
Aspira Women's Health
AWH
|
13.3 M | - | -6.19 % | $ 10.5 M | ||
|
DexCom
DXCM
|
918 M | $ 62.84 | -4.93 % | $ 24.5 B | ||
|
Accelerate Diagnostics
AXDX
|
34.9 M | - | -61.36 % | $ 2.46 M | ||
|
Global Cord Blood Corporation
CO
|
6.66 B | - | - | $ 399 M | ||
|
Fulgent Genetics
FLGT
|
55.1 M | $ 15.54 | -5.13 % | $ 470 M | ||
|
Genetic Technologies Limited
GENE
|
11.7 M | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
176 M | - | 0.12 % | $ 80.1 M | ||
|
Guardant Health
GH
|
378 M | $ 84.0 | -4.65 % | $ 10.5 B | ||
|
HTG Molecular Diagnostics
HTGM
|
12.2 M | - | -20.0 % | $ 1.06 M | ||
|
Castle Biosciences
CSTL
|
120 M | $ 24.0 | -2.83 % | $ 667 M | ||
|
Charles River Laboratories International
CRL
|
214 M | $ 158.89 | -3.78 % | $ 7.88 B | ||
|
Quest Diagnostics Incorporated
DGX
|
420 M | $ 195.64 | -1.27 % | $ 21.7 B | ||
|
Organovo Holdings
ONVO
|
11.3 M | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
1.31 M | - | -16.95 % | $ 1.54 M | ||
|
DarioHealth Corp.
DRIO
|
21.8 M | $ 8.45 | - | $ 33.7 M | ||
|
ICON Public Limited Company
ICLR
|
752 M | $ 102.3 | -0.76 % | $ 8.44 B | ||
|
IDEXX Laboratories
IDXX
|
180 M | $ 561.97 | -1.98 % | $ 45.2 B | ||
|
Biocept
BIOC
|
12.9 M | - | -13.05 % | $ 7.29 M | ||
|
Illumina
ILMN
|
1.13 B | $ 117.62 | -5.45 % | $ 18.7 B | ||
|
PerkinElmer
PKI
|
920 M | - | -0.91 % | $ 14.7 B | ||
|
Invitae Corporation
NVTA
|
257 M | - | - | $ 21.2 M | ||
|
Interpace Biosciences
IDXG
|
1.46 M | $ 1.68 | -2.89 % | $ 7.37 M | ||
|
Medpace Holdings
MEDP
|
497 M | $ 452.91 | -2.94 % | $ 13.1 B | ||
|
Mettler-Toledo International
MTD
|
66.9 M | $ 1 233.1 | -2.91 % | $ 25.4 B | ||
|
Myriad Genetics
MYGN
|
150 M | $ 4.38 | -5.19 % | $ 406 M | ||
|
ENDRA Life Sciences
NDRA
|
3.23 M | $ 4.26 | -7.19 % | $ 2.29 M | ||
|
NeoGenomics
NEO
|
160 M | $ 7.35 | -5.28 % | $ 942 M | ||
|
IQVIA Holdings
IQV
|
1.98 B | $ 164.54 | -2.87 % | $ 28.3 B | ||
|
Motus GI Holdings
MOTS
|
4.96 M | - | -34.28 % | $ 263 K | ||
|
National Research Corporation
NRC
|
4.14 M | $ 17.2 | -0.95 % | $ 385 M | ||
|
QIAGEN N.V.
QGEN
|
598 M | - | - | $ 10.6 B | ||
|
Natera
NTRA
|
466 M | $ 184.45 | -5.96 % | $ 18.2 B | ||
|
OPKO Health
OPK
|
427 M | $ 1.15 | -1.79 % | $ 798 M |